Latest On-Demand Webinars

Water is essential for life and for the successful operation of most of today’s commercial buildings. For most of us though our greatest regular interaction with it is to just turn on a tap. If water is not managed properly, however, it can have a significant and profound effect on the health of the people occupying those buildings too.

Watch this webinar to learn more about applications for screening and characterizing antibody and antibody fragments plus a label-free technology which uses surface plasmon resonance (a biophysical technology) for characterizing antibodies.

Amplicon-based sequencing approaches have been widely adopted for routine microbiology applications, including targeted 16S rRNA for bacterial taxonomic classification and tiled multiplex PCR for viral whole-genome sequencing.

The nitrocellulose membrane (NC) is the heart of a lateral flow assay. It is where the target and control molecules are captured and where the test results are read.
Join our webinar, hosted by Klaus Hochleitner, to take a deep dive into nitrocellulose membranes including the raw material, structure manufacturing process and capillary flow time and how these affect your lateral flow assays.
Klaus will also cover the effect of surfactants on protein binding and membrane properties and how to deal with unspecific binding of proteins to nitrocellulose membranes.

Antibodies are ideal therapeutic biomolecules due to their ability to bind to a variety of targets with high affinity and specificity. Innovations in hybridoma and phage display technologies have enabled drug developers to exploit the natural diversity in antibodies, leading to the wide use of monoclonal antibodies.

Join our webinar, hosted by Klaus Hochleitner, to discuss key considerations for lateral flow test development and optimization and troubleshooting techniques for different samples, tests and antibodies.

Natural killer (NK) cells are a promising tool in the fight against cancer. Engineering them with chimeric antigen receptors (CARs) further bolsters their specific anti-tumor activity.

This webinar describes how a new platform for high-throughput proteomics was used to identify multiple proteins associated with ovarian cancer. A 22-protein model was derived that discriminates ovarian cancer cases from benign controls with high accuracy.

This exclusive Ask Me Anything session delves into the cutting-edge advancements and international policy changes driving sustainability in the laboratory.

In this webinar, our expert speaker Dr. Phillip Kim from the University of Toronto will be discussing the ML methods he currently implements in his lab that enables de novo antibody design. He will also cover ML-based sequence design and scoring methods, as well as diffusion models.